NIH licensing performance under par.
Explore the source record for details and available documents.
Biotechnology↗
Biomedical subjects
Ken Garber
Publications and source records attributed to Ken Garber.
Big plans for small molecules: NIH launches chemical genomics initiative.
Explore the source record for details and available documents.
Animals↗
Research retreat: Pfizer eliminates Sugen, shrinks cancer infrastructure.
Explore the source record for details and available documents.
Angiogenesis Inhibitors↗
Why it hurts: researchers seek mechanisms of cancer pain.
Explore the source record for details and available documents.
Acidosis↗
Better blocker: RNA interference dazzles research community.
Explore the source record for details and available documents.
Animals↗
ODAC panel gives nod to Bexxar.
Explore the source record for details and available documents.
Antibodies, Monoclonal↗
Lymphoma market turf war imminent, pending Bexxar approval.
Explore the source record for details and available documents.
Antibodies, Monoclonal↗
Sugen falls as casualty of Pfizer-Pharmacia merger.
Explore the source record for details and available documents.
Antineoplastic Agents↗
US NHGRI launches chemical attack on drug development gap.
Explore the source record for details and available documents.
Drug Design↗
For Bexxar, FDA meeting offers long-awaited chance at approval.
Explore the source record for details and available documents.
Antibodies, Monoclonal↗
Synthetic lethality: killing cancer with cancer.
Explore the source record for details and available documents.
Animals↗
Breaking the silence: the rise of epigenetic therapy.
Explore the source record for details and available documents.
Genetic Therapy↗
Silence of the genes: cancer epigenetics arrives.
Explore the source record for details and available documents.
Acetyltransferases↗
On the eve of protein destruction: ubiquitin research begins to pay off.
Explore the source record for details and available documents.
Antineoplastic Combined Chemotherapy Protocols↗
Battle over generic taxol concludes, but controversy continues.
Explore the source record for details and available documents.
Clinical Trials as Topic↗
Cancer research. Taking garbage in, tossing cancer out?
Explore the source record for details and available documents.
Animals↗
Could less be more? Low-dose chemotherapy goes on trial.
Explore the source record for details and available documents.
Angiogenesis Inhibitors↗
Angiogenesis inhibitors suffer new setback.
Explore the source record for details and available documents.
Angiogenesis Inhibitors↗